Publications Using GEM Study Data

• Betterman K, Arnold AM, Williamson J, et al. Statins, risk of dementia, and cognitive function: secondary analysis of the Ginkgo Evaluation of Memory Study. Journal of Stroke and Cerebrovascular Diseases. 2012;21(6):436–444.
• Biggs ML, Sorkin BC, Nahin RL, et al. Ginkgo biloba and risk of cancer: secondary analysis of the Ginkgo Evaluation of Memory (GEM) Study. Pharmacoepidemiology and Drug Safety. 2010;19(17):694–698.
• Brinkley TE, Lovato JF, Furberg CD, et al. Effect of Ginkgo biloba on blood pressure and incidence of hypertension in elderly men and women. American Journal of Hypertension. 2010;23(5):528–533.
• Chapman B, Duberstein P, Tindle HA, et al. Personality predicts cognitive function over 7 years in older persons. American Journal of Geriatric Psychiatry. 2012;20(7):612–621.
• Dar-Nimrod I, Chapman BP, Franks P, et al. Personality factors moderate the associations between apolipoprotein genotype and cognitive function as well as late onset Alzheimer disease. American Journal of Geriatric Psychiatry. 2012;20(12):1026–1035.
• DeKosky ST, Fitzpatrick A, Ives DG, et al. The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia. Contemporary Clinical Trials. 2006;27(3):238–253.
• DeKosky ST, Furberg CD. Turning over a new leaf: Ginkgo biloba in prevention of dementia? Neurology 2008;70(19 Pt 2):1730–1731.
• DeKosky ST, Williamson JD, Fitzpatrick AL, et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA. 2008;300(19):2253–2262.
• Duberstein PR, Chapman BP, Tindle HA, et al. Personality and risk for Alzheimer’s disease in adults 72 years of age and older: a 6-year follow-up. Psychology and Aging. 2011;26(2):351–362.
• Fitzpatrick AL, Buchanan CK, Nahin RL, et al. Association of gait speed and other measures of physical function with cognition in a healthy cohort of elderly persons. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 2007;62(11):1244–1251.
• Fitzpatrick AL, Fried LP, Williamson J, et al. Recruitment of the elderly into a pharmacologic prevention trial: the Ginkgo Evaluation of Memory Study experience. Contemporary Clinical Trials. 2006:27(6);541–553.
• Jerant A, Chapman B, Duberstein P, et al. Personality and medication non-adherence among older adults enrolled in a six-year trial. British Journal of Health Psychology. 2011;16(Pt 1):151–169.
• Kuller LH, Ives DG, Fitzpatrick AL, et al. Does Ginkgo biloba reduce risk of cardiovascular events? Circulation. Cardiovascular Quality and Outcomes. 2010;3(1):41–47.
• Mohanty JG, Eckley DM, Williamson JD, et al. Do red blood cell-beta-amyloid interactions alter oxygen delivery in Alzheimer’s disease? Advances in Experimental Medicine and Biology. 2008;614:29–35.
• Mohanty JG, Shukla HD, Williamson JD, et al. Alterations in the red blood cell membrane proteome in Alzheimer’s subjects reflect disease-related changes and provide insight into altered cell morphology. Proteome Science. 2010;8:11.
• Nahin RL, Fitzpatrick AL, Williamson JD, et al. Use of herbal medicine and other dietary supplements in community-dwelling older people: baseline data from the Ginkgo Evaluation of Memory Study. Journal of the American Geriatrics Society. 2006;54(11):1725–1735.
• Nahin R, Pecha M, Welmerink DB, et al. Concomitant use of prescription drugs and dietary supplements in the ambulatory elderly. Journal of the American Geriatrics Society. 2009;57(7):1197–1205.
• Rosano C, Aizenstein H, Cochran J, et al. Event-related functional magnetic resonance imaging investigation of executive control in very old individuals with mild cognitive impairment. Biological Psychiatry. 2005;57(7):761–767.
• Rosano C, Aizenstein H, Cochran J, et al. Functional neuroimaging indicators of successful executive control in the oldest old. Neuroimage. 2005;28(4):881–889.
• Saxton J, Snitz BE, Lopez OL, et al. Functional and cognitive criteria produce different rates of mild cognitive impairment and conversion to dementia. Journal of Neurology, Neurosurgery, and Psychiatry. 2009;80(7):737–743.
• Snitz BE, O’Meara ES, Carlson MC, et al. Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA. 2009;302(24):2663–2670.
• Snitz BE, Saxton J, Lopez OL, et al. Identifying mild cognitive impairment at baseline in the Ginkgo Evaluation of Memory (GEM) study. Aging & Mental Health. 2009;13(2):171–182.
• Tate JA, Angus D, Weissfeld L, et al. Hospitalization for pneumonia is associated with increased risk of dementia in older adults. American Journal of Respiratory and Critical Care Medicine. 2012;185(1 Meeting Abstracts):A2310.
• Williamson JD, Vellas B, Furberg C, et al. Comparison of the design differences between Ginkgo Evaluation of Memory Study and the GuidAge Study. Journal of Nutrition, Health & Aging. 2008;12(1):73S–79S.
• Yasar S, Lin F-M, Fried LP, et al. Diuretic use is associated with better learning and memory in older adults in the Ginkgo Evaluation Memory Study. Alzheimer’s & Dementia. 2012;8(3):188–195.

Search PubMed for additional publications

Date Updated: November 2012